Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 5 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Kidney Neoplasms 2 Colorectal Neoplasms 2 Uterine Neoplasms 1 Thyroid Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Anastomotic Leak 1

Interventions

Fluorouracil 34 Leucovorin 31 Oxaliplatin 25 Irinotecan 19 Capecitabine 13 Folfox protocol 12 Cetuximab 12 Chemotherapy, Adjuvant 11 Bevacizumab 9 Neoadjuvant Therapy 8 Drug Therapy 8 XELOX 7 Laparoscopy 7 Endoscopic Mucosal Resection 5 Colonoscopy 5 Surgical Procedures, Operative 4 Gemcitabine 4 Tegafur 3 Radiotherapy 3 Propofol 3 Preoperative Exercise 3 Panitumumab 3 Fentanyl 3 Curcumin 3 Colectomy 3 Aspirin 3 raltitrexed 2 Surveys and Questionnaires 2 Sodium Chloride 2 Simvastatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colonic Neoplasms × Robotic Surgical Procedures × Clear all

NCT03696472 2018-10-09

RALH

Southwest Hospital, China

Phase NA Unknown

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡